Related Experiment Video
Updated: May 11, 2026

Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death
Published on: December 21, 2016
Blood lead levels and serum insulin-like growth factor 1 concentrations in peripubertal boys
Abby F Fleisch1, Jane S Burns, Paige L Williams
1Department of Endocrinology, Children's Hospital Boston, Boston, Massachusetts, USA.
Insights
Childhood lead exposure, measured by blood lead levels (BLLs), is linked to lower insulin-like growth factor 1 (IGF-1) in boys. This suggests lead may impact growth by affecting the hypothalamic-pituitary-growth axis.
Area of Science:
- Environmental Health
- Pediatric Endocrinology
- Toxicology
Background:
- Childhood lead exposure is a known risk factor for growth delay.
- The specific relationship between blood lead levels (BLLs) and insulin-like growth factor 1 (IGF-1) in low-level exposure scenarios remains under-characterized in large cohorts.
Purpose of the Study:
- To investigate the association between baseline blood lead levels (BLLs) and serum insulin-like growth factor 1 (IGF-1) concentrations in a cohort of boys.
- To determine if lead exposure impacts growth markers in children with low-level exposure.
Main Methods:
- Recruited 394 boys aged 8-9 years from an industrial Russian town.
- Employed linear regression models to assess the association between baseline BLLs and serum IGF-1 at ages 10-11 and 12-13 years.
- Adjusted for demographic, socioeconomic, and pubertal status covariates.
Main Results:
- A median BLL of 3 μg/dL was observed at baseline; 86% of boys were prepubertal.
- Higher BLLs were significantly associated with lower mean serum IGF-1 concentrations at follow-up (e.g., -29.2 ng/mL difference for BLLs ≥ 5 μg/dL vs. < 5 μg/dL).
- The inverse association between BLLs and IGF-1 was more pronounced in mid-pubertal boys and showed a dose-response relationship across different BLL categories.
Conclusions:
- Elevated blood lead levels in peripubertal boys with low-level exposure are associated with reduced serum IGF-1.
- Lead exposure may contribute to growth delay through potential inhibition of the hypothalamic-pituitary-growth axis.
Background:
Childhood lead exposure has been associated with growth delay. However, the association between blood lead levels (BLLs) and insulin-like growth factor 1 (IGF-1) has not been characterized in a large cohort with low-level lead exposure.
Methods:
We recruited 394 boys 8-9 years of age from an industrial Russian town in 2003-2005 and followed them annually thereafter. We used linear regression models to estimate the association of baseline BLLs with serum IGF-1 concentration at two follow-up visits (ages 10-11 and 12-13 years), adjusting for demographic and socioeconomic covariates.
Results:
At study entry, median BLL was 3 μg/dL (range, < 0.5-31 μg/dL), most boys (86%) were prepubertal, and mean ± SD height and BMI z-scores were 0.14 ± 1.0 and -0.2 ± 1.3, respectively. After adjustment for covariates, the mean follow-up IGF-1 concentration was 29.2 ng/mL lower (95% CI: -43.8, -14.5) for boys with high versus low BLL (≥ 5 μg/dL or < 5 μg/dL); this difference persisted after further adjustment for pubertal status. The association of BLL with IGF-1 was stronger for mid-pubertal than prepubertal boys (p = 0.04). Relative to boys with BLLs < 2 μg/dL, adjusted mean IGF-1 concentrations decreased by 12.8 ng/mL (95% CI: -29.9, 4.4) for boys with BLLs of 3-4 μg/dL; 34.5 ng/mL (95% CI: -53.1, -16.0) for BLLs 5-9 μg/dL; and 60.4 ng/mL (95% CI: -90.9, -29.9) for BLLs ≥ 10 μg/dL.
Conclusions:
In peripubertal boys with low-level lead exposure, higher BLLs were associated with lower serum IGF-1. Inhibition of the hypothalamic-pituitary-growth axis may be one possible pathway by which lead exposure leads to growth delay.
Related Concept Videos
Signs of Puberty
Hypoglycemia
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Testosterone: Functions and Regulation
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Serum Studies: Renal Function Tests
